Attock Petroleum Ltd
Fundamental Score
Attock Petroleum Ltd Share Price Live NSE/BSE
Profitability Metrics
Return on Equity
Return on Capital Employed
Operating Profit Margin (5Y)
Dividend Yield
Valuation Metrics
Price to Earnings
Market Capitalization
Industry P/E
Growth Metrics
YoY Quarterly Profit Growth
YoY Quarterly Sales Growth
Sales Growth (5Y)
EPS Growth (5Y)
Profit Growth (5Y)
Financial Health
Debt to Equity
Interest Coverage
Free Cash Flow (5Y)
Ownership Structure
Promoter Holding
FII Holding
DII Holding
Pledged Percentage
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Market Data Analysis & Educational Insights
Educational evaluation of APL across key market metrics for learning purposes.
Positive Indicators
8 factors identified
Strong Return on Equity (41.85%)
Observation: Efficient use of shareholders' capital generating superior returns.
Analysis: ROE >15% indicates strong profitability and effective management. This metric suggests the company can generate substantial returns on invested capital.
Excellent ROCE Performance (36.62%)
Observation: Superior returns on capital employed across business operations.
Analysis: ROCE >15% demonstrates efficient capital deployment and strong operational performance. This indicates quality business fundamentals.
Attractive Valuation (P/E: 15.49 vs Industry: 31.77)
Observation: Trading at discount to industry peers.
Analysis: P/E below industry average may present value opportunity if fundamentals support the business case.
Robust Profit Growth (77.89%)
Observation: Strong year-over-year profit expansion demonstrates business momentum.
Analysis: Profit growth >20% indicates effective execution and market opportunity capture. This suggests positive business trajectory.
Conservative Debt Levels (D/E: 0.10)
Observation: Low leverage provides financial flexibility and reduced risk.
Analysis: Conservative debt structure offers resilience during economic downturns and flexibility for growth investments.
Strong Interest Coverage (8.32x)
Observation: Earnings comfortably cover interest obligations.
Analysis: Interest coverage >5x indicates low financial distress risk and strong debt servicing capability.
Balanced Promoter Holding (50.66%)
Observation: Optimal balance between promoter control and public float.
Analysis: Promoter holding in 50-75% range provides management alignment while ensuring adequate liquidity.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral, reducing forced-selling risk.
Analysis: Absence of share pledging eliminates potential forced-selling pressure during market stress.
Risk Factors
3 factors identified
Limited Institutional Interest (FII+DII: 6.04%)
Observation: Low institutional participation may affect liquidity and visibility.
Analysis: Limited institutional interest may indicate size constraints or visibility issues in the investment community.
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints. Assess capital allocation strategy.
Small Market Cap
Observation: Higher investment risk due to limited size.
Analysis: Small-cap stocks typically carry higher volatility and liquidity risks.
Financial Statements
Comprehensive financial data for Attock Petroleum Ltd
About APL
Business Overview
Asston Pharmaceuticals Limited manufactures pharmaceutical products in India, West Africa, South Africa, and Asian countries. The company provides tablets, such as aceclofenac, albendazole, aminophylline, artemether and lumefantrine, ascorbic acid chewable, azithromycin, b-complex, calcium, cholecalciferol with folic acid, cefixime, cetirizine, ciprofloxacin, co-trimoxazole, cyproheptadine, dexamethasone, diclofenac, ferrous sulphate, folic acid, glucose, griseofulvin, levofloxacin, loperamide HCL, losartan potassium, mebendazole, metformin hydrochloride sustained release, metformin hydrochloride, metronidazole, multivitamin, nitrofurantoin, ofloxacin and ornidazole, pantoprazole, paracetamol, paracetamol, phenylephrine HCL, chlorpheniramine maleate and caffeine, prednisolone, pregabalin SR and methylcobalamin, pyridoxine HCL, rifampicin and isoniazid, rifampicin, isoniazid, pyrazinamide and ethambutol HCL, sildenafil, tadalafil, telmisartan, and zinc sulphate. It also offers capsules, including amoxicillin, ampicillin and cloxacillin, ampicillin, b-complex, cloxacillin, danazol, diclofenac, ibuprofen, paracetamol, caffeine, indomethacin, itraconazole, mecobalamin, alpha lipoic acid, thiamine mononitrate, pyridoxine HCL and folic acid, mefenamic acid, multivitamin, omeprazole, pregabalin, rabeprazole sodium and domperidone SR, rifabutin, and rifampicin; and oral suspension and syrup, which includes albendazole, amodiaquine, antacid, artemether and lumefantrine dry, azithromycin dry, b-complex, cefixime dry, chloroquine, co-trimoxazole, iron, kids cold, kids cough, mebendazole, metronidazole, multivitamin, and paracetamol. In addition, the company provides sachets and oral powder comprising oral rehydration salt, vitamin d3, glucose powder, sorbitol powder, prebiotic and probiotic, and antacids. It sells its products in the form of tablet capsules, syrup, sachet, and injection. The company was incorporated in 2019 and is based in Navi Mumbai, India.
Company Details
Key Leadership
Latest News
APL Stock Details & Analysis
Key Financial Metrics
Growth & Valuation
Frequently Asked Questions
What is the current price of Attock Petroleum Ltd (APL)?
As of 10 Feb 2026, 10:13 am IST, Attock Petroleum Ltd (APL) is currently trading at ₹81.00. The stock has a market capitalization of ₹82.57 (Cr).
Is APL share price Overvalued or Undervalued?
APL is currently trading at a P/E ratio of 15.49x, compared to the industry average of 31.77x. Based on this relative valuation, the stock appears to be Undervalued against its sector peers.
What factors affect the Attock Petroleum Ltd share price?
Key factors influencing APL's price include its quarterly earnings growth (Sales Growth: -3.44%), raw material costs, government infrastructure spending, and institutional flows (FII/DII holding).
Is Attock Petroleum Ltd a good stock for long-term investment?
Attock Petroleum Ltd shows a 5-year Profit Growth of N/A% and an ROE of 41.85%. Long-term investors should consider these fundamentals alongside the debt-to-equity ratio of 0.10 before investing.
How does Attock Petroleum Ltd compare with its industry peers?
Attock Petroleum Ltd competes with major peers in the Pharmaceuticals. Investors should compare APL's P/E of 15.49x and ROE of 41.85% against the industry averages to determine its competitive standing.
What is the P/E ratio of APL and what does it mean?
APL has a P/E ratio of 15.49x compared to the industry average of 31.77x. The Price-to-Earnings (P/E) ratio is calculated by dividing the current share price by earnings per share (EPS). This means investors are paying ₹15 for every ₹1 of annual earnings.
How is APL performing according to Bull Run's analysis?
APL has a Bull Run fundamental score of 40.8/100, which indicates concerns that require careful analysis. This comprehensive rating is based on 15+ financial parameters including profitability, growth metrics, and valuation ratios.
What sector and industry does APL belong to?
APL operates in the Pharmaceuticals industry. This classification helps understand the competitive landscape and sector-specific trends affecting Attock Petroleum Ltd.
What is Return on Equity (ROE) and why is it important for APL?
APL has an ROE of 41.85%, which indicates excellent management efficiency and profitable operations. Return on Equity measures how efficiently Attock Petroleum Ltd generates profits from shareholders' equity.
How is APL's debt-to-equity ratio and what does it indicate?
APL has a debt-to-equity ratio of 0.10, which indicates conservative financing with low financial risk. A ratio below 1.0 generally indicates conservative financing.
What is APL's dividend yield and is it a good dividend stock?
APL offers a dividend yield of 0.00%, which means you receive ₹0.00 annual dividend for every ₹100 invested.
How has APL grown over the past 5 years?
APL has achieved 5-year growth rates of: Sales Growth N/A%, Profit Growth N/A%, and EPS Growth N/A%.
What is the promoter holding in APL and why does it matter?
Promoters hold 50.66% of APL shares, with 0.00% of promoter shares pledged. High promoter holding often indicates strong management confidence.
What is APL's market capitalization category?
APL has a market capitalization of ₹83 crores, placing it in the Small-cap category.
How volatile is APL stock?
APL has a beta of N/A. A beta > 1 suggests the stock is more volatile than the market, while a beta < 1 suggests it is less volatile.
What is the 52-week high and low for APL?
APL has a 52-week high of ₹N/A and low of ₹N/A.
What is APL's operating profit margin trend?
APL has a 5-year average Operating Profit Margin (OPM) of N/A%, indicating the company's operational efficiency.
How is APL's quarterly performance?
Recent quarterly performance shows YoY Sales Growth of -3.44% and YoY Profit Growth of 77.89%.
What is the institutional holding pattern in APL?
APL has FII holding of 6.04% and DII holding of 0.00%. Significant institutional holding often suggests professional confidence in the stock.